OCGN 240816 2.50C (OCGN240816C2500) Stock Options, News & Quotes

US OptionsDetailed Quotes

OCGN240816C2500

Watchlist

0.03
+0.02+200.00%

15min DelayClose Jul 24 11:48 ET

0.05High0.03Low

Intraday

5D
Daily

News

Trending Stocks Today: NANO Nuclear Energy Inches up 8.83% Post-Market
Moomoo NewsJun 28 16:30 ET
Sector Update: Health Care Stocks Steady Premarket Friday
MT NewswiresJun 21 09:12 ET
Ocugen's Receives Nod to Enrol in High Dose Study of Stargardt Disease Drug Candidate
MT NewswiresJun 21 08:04 ET
Express News | Ocugen Announces Data and Safety Monitoring Board Approves Enrollment in High Dose Cohort 3 in Gardian Study for Stargardt Disease
ReutersJun 21 07:00 ET
Ocugen Announces Data and Safety Monitoring Board Approves Enrollment in High Dose Cohort 3 in GARDian Study for Stargardt Disease
OcugenJun 21 00:00 ET
Express News | Ocugen Shares Are Trading Lower. The Company Announced That the First Patient Has Been Dosed in Its Phase 3 LiMeliGhT Clinical Trial for OCU400—a Modifier Gene Therapy Product Candidate Being Developed for Retinitis Pigmentosa
BenzingaJun 20 11:25 ET

Comments

104534386

Jul 17 03:39

$Ocugen(OCGN.US)$ i regret not buying this share

porsh

Jul 15 08:19

$Ocugen(OCGN.US)$ yes slow and steady

hui3897

Jul 13 16:39

$Ocugen(OCGN.US)$ slow and steady

Trytosaveabit

Jun 21 06:00

Update

$Ocugen(OCGN.US)$ Reuters· just
Ocugen Announces Data and Safety Monitoring Board Approves Enrollment in High Dose Cohort 3 in Gardian Study for Stargardt Disease

mizmo

Jun 12 08:39

$Ocugen (OCGN.US)$ it squeezed at this time last year so you might as well jump in a month before earnings if that's where you're minds at